Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements.
Understanding Austedo in Treating Tardive Dyskinesia
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements. These movements can affect the face, limbs, and trunk, often causing significant distress and impacting daily life. Austedo (deutetrabenazine) is a prescription medication specifically approved to treat tardive dyskinesia in adults. This article explores what tardive dyskinesia is, how Austedo works, and important considerations for its use.
What is Tardive Dyskinesia?
Tardive dyskinesia is a movement disorder that can develop as a side effect of certain medications, particularly older antipsychotics used to treat psychiatric conditions like schizophrenia and bipolar disorder, and some anti-nausea drugs. The term "tardive" means delayed, referring to the fact that symptoms often appear after months or years of medication use, or even after the medication has been discontinued.
Symptoms of Tardive Dyskinesia
The involuntary movements associated with TD can vary widely, but commonly include:
- Facial movements: Lip smacking, chewing motions, grimacing, blinking, tongue protrusion.
- Trunk movements: Rocking, swaying, or twisting movements of the torso.
- Limb movements: Finger wiggling, foot tapping, or rapid, jerking movements of the arms and legs.
These movements are often persistent and can be difficult to control, leading to self-consciousness and functional impairment.
Causes and Risk Factors
TD is thought to be caused by changes in dopamine signaling in the brain, often induced by long-term use of dopamine receptor blocking agents. While not everyone who takes these medications will develop TD, certain factors can increase the risk, including older age, female gender, longer duration of medication use, higher doses, and pre-existing mood disorders.
How Austedo Works for Tardive Dyskinesia
Austedo (deutetrabenazine) is a medication that helps to control the involuntary movements associated with tardive dyskinesia. It belongs to a class of drugs known as vesicular monoamine transporter 2 (VMAT2) inhibitors.
Mechanism of Action
VMAT2 is a protein responsible for packaging neurotransmitters like dopamine into vesicles before they are released into the synapse. By inhibiting VMAT2, Austedo reduces the amount of dopamine available at the nerve endings, thereby decreasing the excessive dopamine activity believed to contribute to TD symptoms. This modulation of dopamine helps to reduce the involuntary movements without completely blocking dopamine's essential functions.
Efficacy and Clinical Studies
Clinical trials have demonstrated Austedo's effectiveness in significantly reducing the severity of tardive dyskinesia symptoms compared to placebo. Patients treated with Austedo experienced measurable improvements in their involuntary movements, as assessed by standardized rating scales. These improvements were sustained over the course of treatment.
Important Considerations When Using Austedo
As with any prescription medication, Austedo comes with important considerations regarding its use, including dosage, potential side effects, and precautions. It is crucial for individuals to discuss these aspects thoroughly with their healthcare provider.
Dosage and Administration
Austedo is taken orally, typically twice daily. The dosage is usually started low and gradually increased by a healthcare provider based on the individual's response and tolerability. It's important to follow the prescribed dosage regimen strictly and not to adjust it without medical guidance.
Potential Side Effects
While generally well-tolerated, Austedo can cause side effects. Common side effects may include:
- Sedation or drowsiness
- Diarrhea
- Dry mouth
- Insomnia
- Fatigue
- Nausea
More serious, though less common, side effects can occur. These might include QT prolongation (a heart rhythm abnormality), depression, suicidal thoughts, neuroleptic malignant syndrome (a rare but serious reaction), or parkinsonism (symptoms similar to Parkinson's disease). Any new or worsening side effects should be reported to a doctor immediately.
Precautions and Contraindications
Austedo may not be suitable for everyone. It is contraindicated in individuals with Huntington's disease, or those who are taking reserpine or monoamine oxidase inhibitors (MAOIs). Precautions are also necessary for patients with liver impairment, certain heart conditions, or a history of depression or suicidal thoughts. A comprehensive medical history and evaluation are essential before starting Austedo.
Living with Tardive Dyskinesia and Treatment Options
Living with tardive dyskinesia can be challenging, but effective treatments like Austedo offer hope for managing symptoms and improving quality of life. In addition to medication, a holistic approach that may include supportive therapies and lifestyle adjustments can be beneficial. Close collaboration with a neurologist or a movement disorder specialist is key to developing an individualized treatment plan.
This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.